Cytomegalovirus vaccines and methods of production (WO20009049138): the emerging recognition of the importance of virus neutralization at the epithelial/endothelial interface

Bibliography

• Demmler GJ. Congenital cytomegaloviral infection and disease. Semin Pediatr Infect Dis 1999;10:195-200
   Google Scholar
• Stagno S, Pass RF, Cloud G, Primary cytomegalovirus infection in pregnancy. Incidence, transmission to the fetus, and clinical outcome. JAMA 1986;256:1904-8
   PubMed Web of Science ®Google Scholar
• Bale JF, Miner L, Petheram SJ. Congenital cytomegalovirus infection. Curr Treat Options Neurol 2002;4:225-30
   PubMedGoogle Scholar
• Cannon MJ, Finn Davis K. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005;5:70-7
   PubMed Web of Science ®Google Scholar
• Ahlfors K, Ivarsson SA, Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis 1999;31:443-57
   PubMedGoogle Scholar
• Boppana SB, Rivera LB, Fowler KB, Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001;344:1366-71
   PubMed Web of Science ®Google Scholar
• Novak Z, Ross SA, Patro RK, Cytomegalovirus strain diversity in seropositive women. J Clin Microbiol 2008;46:882-6
   PubMed Web of Science ®Google Scholar
• Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253-76
   PubMed Web of Science ®Google Scholar
• Fowler KB, Stagno S, Pass RF, The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663-7
   PubMed Web of Science ®Google Scholar
• Fowler KB, Stagno S, Pass RP. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 2003;289:1008-11
   PubMed Web of Science ®Google Scholar
• Stratton KR, Durch JS, Lawrence RS, editors. Vaccines for the 21st century: a tool for decisionmaking. Committee to Study Priorities for Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine, Washington, DC; 1999
   Google Scholar
• Arvin AM, Fast P, Myers M, Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine Advisory Committee. Clin Infect Dis 2004;39:233-9
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Vaccination against cytomegalovirus, the changeling demon. Pediatr Infect Dis J 1999;18:313-25
   PubMed Web of Science ®Google Scholar
• Pass RF, Burke RL. Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection. Semin Pediatr Infect Dis 2002;13:196-204
   PubMedGoogle Scholar
• Schleiss MR, Heineman TC. Progress toward an elusive goal: current status of cytomegalovirus (CMV) vaccines. Exp Rev Vaccines 2005;4:381-406
   PubMed Web of Science ®Google Scholar
• Adler SP, Starr SE, Plotkin SA, Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis 1995;171:26-32
   PubMed Web of Science ®Google Scholar
• Heineman TC, Schleiss M, Bernstein DI, A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines. J Infect Dis 2006;193:1350-60
   PubMed Web of Science ®Google Scholar
• Pass RF, Zhang C, Evans A, Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009;360:1191-9
   PubMed Web of Science ®Google Scholar
• Nicola AV, Mcevoy AM, Straus SE. Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J Virol 2003;77:5324-32
   PubMed Web of Science ®Google Scholar
• Hahn G, Revello M, Patrone M, Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 2004;78:10023-33
   PubMed Web of Science ®Google Scholar
• Gerna G, Percivalle E, Lilleri D, Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J Gen Virol 2005;86:275-84
   PubMedGoogle Scholar
• Wang D, Shenk T. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci USA 2005;102:18153-8
   PubMed Web of Science ®Google Scholar
• Ryckman BJ, Jarvis MA, Drummond DD, Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol 2006;80:710-22
   PubMed Web of Science ®Google Scholar
• Ryckman BJ, Chase MC, Johnson DC. HCMV TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions, but is not present in virions. J Virol 2009. [Epub ahead of print] PMID: 20032193
   PubMedGoogle Scholar
• Wille PT, Knoche AJ, Nelson JA, An HCMV gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts, epithelial, and endothelial cells. J Virol 2009. [Epub ahead of print] PMID: 20032184
   PubMedGoogle Scholar
• Ryckman BJ, Rainish BL, Chase MC, Characterization of the human cytomegalovirus gH/gL/UL128 – 131 complex that mediates entry into epithelial and endothelial cells. J Virol 2008;82:60-70
   PubMed Web of Science ®Google Scholar
• Ryckman BJ, Chase MC, Johnson DC. HCMV gH/gL/UL128 – 131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors. Proc Natl Acad Sci USA 2008;105:14118-23
   PubMed Web of Science ®Google Scholar
• Cui X, Meza BP, Adler SP, Mcvoy MA. Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection. Vaccine 2008;26:5760-6
   PubMed Web of Science ®Google Scholar
• Gerna G, Sarasini A, Patrone M, Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J Gen Virol 2008;89:853-65
   PubMed Web of Science ®Google Scholar
• Macagno A, Bernasconi NL, Vanzetta F, Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128 – 131A complex. J Virol 2010;84:1005-13, [Epub ahead of print] PMID: 19889756
   PubMed Web of Science ®Google Scholar
• Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis 1990;12(S7):S701-10
   Google Scholar
• Nigro G, Adler SP, Latorre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350-62
   PubMed Web of Science ®Google Scholar